
The Berkem Group announces the acquisition of Laboratoires Eriger, a company specializing in technologies derived from pharmaceutical research for the cosmetics industry. This acquisition enables Berkem to integrate its patented PhytoVec technology, a process for encapsulating active plant ingredients using chlorophyll.
“We are delighted to integrate Laboratoires Eriger’s cutting-edge technology into our group. The production tools will be transferred to our industrial site in Chartres, a city synonymous with excellence and competitiveness for international players in the cosmetics industry. Laboratoires Eriger’s recognized know-how will be an invaluable asset in consolidating our expertise in plant-based chemistry and strengthening our position in the active cosmetics market. Their patented PhytoVec technology, which micro-encapsulates plant active ingredients thanks to the chlorophyll they contain, is a major breakthrough that we intend to deploy to its full potential within our ‘Health, Beauty & Nutrition’ division. In markets constantly seeking naturalness, the integration of Laboratoires Eriger’s active ingredients represents a major step forward, enabling us to offer our customers and prospects ever more innovative solutions. I would also like to express my sincere thanks to Eric Buchy for his commitment and invaluable support throughout this operation,” said Olivier Fahy, Chairman and CEO of Groupe Berkem.
With this transaction, Berkem intends to strengthen its cosmetics offering. The acquisition was finalized on March 6, 2025, with financial terms kept confidential.












